Breaking News

Sanofi SA (SASY)

Symbol	Exchange	Currency
SASY	Paris	EUR	Real-time
SANp	BATS Europe	EUR	Delayed
SNY	NASDAQ	USD	Real-time
0O59	London	EUR	Real-time
SNYN	Mexico	MXN	Delayed
SANF	Milan	EUR	Real-time
SASY	TradeGate	EUR	Delayed
SASY	Frankfurt	EUR	Delayed
SASY	Xetra	EUR	Delayed
SASY	Vienna	EUR	Real-time

Add to/Remove from a Portfolio Add to Watchlist

92.20 +0.20 +0.22%

- Delayed Data. Currency in EUR ( Disclaimer )

Volume: 59
Bid/Ask: 91.80 / 92.20
Day's Range: 91.86 - 92.20

Type: Equity

Market: Germany

ISIN: FR0000120578

S/N: 920657

SASY Share Price Overview

Find here information about Sanofi share price. You can find more details about Sanofi shares by going to one of the sections listed on this page such as historical data, price charts, Sanofi stock price technical analysis and more.

Show/Hide News

Technical Chart

Last Update:

1 Day
1 Week
1 Month
3 Months
6 Months
1 Year
5 years
Max

Prev. Close92

Day's Range91.86 - 92.2

Revenue46.29B

Open91.86

52 wk Range81.25 - 104.06

EPS3.63

Volume59

Market Cap114.74B

Dividend (Yield)3.76 (4.2%)

Average Volume (3m)1,193

P/E Ratio24.26

Beta0.452

1-Year Change - 9.36%

Shares Outstanding1,248,557,653

Next Earnings DateJul 25, 2024

What is your sentiment on Sanofi?

Vote to see community's results!

Technical Summary

Type	5 Min	15 Min	Hourly	Daily	Monthly
Moving Averages	Strong Buy	Strong Buy	Buy	Buy	Buy
Technical Indicators	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Sell
Summary	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Neutral

Candlestick Patterns

Filter Table By:

Pattern		Timeframe	Candles Ago	Candle Time
Completed Patterns
	Three Outside Up	1D	4	Apr 22, 2024
	Tri-Star Bearish	15	4	Apr 25, 2024 15:15
	Bullish Engulfing	1D	5	Apr 19, 2024
	Falling Three Methods	1D	7	Apr 17, 2024
	Falling Three Methods	1W	8	Feb 25, 2024

Sanofi SA Quotes

Exchange	Last	Bid	Ask	Volume	Change %	Currency
Paris	91.62	0.00	0.00	3,378,063	+4.47%	EUR
BATS Europe	91.73	90.57	0.00	4,503	+3.36%	EUR
NASDAQ	49.36	47.05	49.36	6,464,961	+5.90%	USD
London	91.58	89.10	92.51	1,702,243	+4.57%	EUR
Mexico	802.00	0.00	0.00	0	+0.00%	MXN
Milan	91.63	0.00	0.00	2,596	+4.41%	EUR
TradeGate	92.08	91.81	92.20	68	+0.33%	EUR
Frankfurt	92.20	91.80	92.20	59	+0.22%	EUR
Xetra	91.900	91.470	93.140	6,527	+4.65%	EUR
Vienna	86.80	86.65	86.78	0	+0.00%	EUR

Trending Stocks

Name	Last	High	Low	Chg.	Chg. %	Vol.	Time
Barclays	204.00	206.70	194.32	+12.86	+6.73%	165.62M
AstraZeneca	12,026.0	12,096.0	11,790.0	+674.0	+5.94%	4.18M
Legal & General	232.80	238.10	231.30	-15.80	-6.36%	28.90M
Anglo American	2,560.0	2,579.5	2,421.0	+355.0	+16.10%	19.17M
Rolls-Royce Holdings	405.70	414.20	400.50	-11.30	-2.71%	89.33M
Lloyds Banking	51.20	52.18	50.92	-0.58	-1.12%	114.47M
IAG	176.15	178.30	173.80	-0.80	-0.45%	14.85M
HSBC	661.90	663.90	657.70	-1.70	-0.26%	24.62M
J Sainsbury	256.60	266.60	254.60	-11.40	-4.25%	11.28M	25/04
BAE Systems	1,320.00	1,358.00	1,290.00	-43.50	-3.19%	7.81M	25/04

%SHORT_NAME% Company Profile

IndustryPharmaceuticals

SectorHealthcare

Employees

91573

Equity Type

ORD

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

SASY Price Commentary

Write your thoughts about Sanofi SA

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Boubacar s b Toure Mar 11, 2023 1:51

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

nzf

0 0

Report

Oct 06, 2022 17:00

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Will eventually do well because of French strategy. France is at the top table and Sanofi was made up by absorbing others to grow. Look at 20% in a couple of years

0 0

Report

Greg Greg Dec 11, 2020 9:36

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

there is no future for it

0 10

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="202781679">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="202781679" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="202781679" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="202781679">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,078.86	+38.48	+0.48%
DAX	17,923.79	-164.91	-0.91%
Euro Stoxx 50	4,939.65	-50.23	-1.01%
S&P 500	5,048.42	-23.21	-0.46%
Nikkei 225	37,943.50	+315.02	+0.84%
Dow Jones	38,085.80	-375.12	-0.98%
FTSE 100 Futures	8,148.2	-3.7	-0.05%

Brent Oil	89.51	+0.50	+0.56%
Crude Oil WTI	84.03	+0.46	+0.55%
Gold	2,350.95	+8.45	+0.36%
Silver	27.633	+0.280	+1.02%
Copper	4.5808	+0.0363	+0.80%
London Cocoa	9,589.00	0.00	0.00%
London Wheat	180.55	+0.60	+0.33%

U.K. 10Y	4.3985	+0.0295	+0.68%
U.K. 5Y	4.2970	+0.0340	+0.80%
U.K. 2Y	4.5290	+0.0360	+0.80%
Germany 10Y	2.6050	-0.0190	-0.72%
U.S. 10Y	4.684	-0.024	-0.51%
U.S. 5Y	4.705	-0.012	-0.26%
U.S. 2Y	4.991	-0.007	-0.13%

Lloyds Banking	51.20	-0.58	-1.12%
Vodafone Group PLC	69.000	-0.340	-0.49%
Barclays	204.00	+12.86	+6.73%
BT Group	104.70	-0.55	-0.52%
HSBC	661.90	-1.70	-0.26%
BHP Group Ltd	2,311.00	-53.00	-2.24%
Exxon Mobil	121.36	+0.31	+0.26%

Recent Quotes

	Name	Price	Chg.	Chg. %
	SASY	92.20	+0.20	+0.22%

Market Movers

Name	Last	Chg. %	Vol.
Barclays	204.00	+6.73%	165.62M
Rolls-Royce Holdings	405.70	-2.71%	89.33M
BP	526.30	+0.13%	61.53M
Anglo American	2,560.0	+16.10%	19.17M
Shell	2,901.0	-0.21%	9.79M
Unilever	4,082.0	+5.67%	8.47M
AstraZeneca	12,026.0	+5.94%	4.18M

Name	Last	Chg. %	Vol.
Kr1	0.73	+100000.00%	15.00K
DMK Pharmaceuticals	0.04	+100000.00%	0.03K
Edgio	10.61	+100000.00%	0.66K
Santhera Pharmaceuticals Holding	9.01	+1297.67%	0.09K
MFE MEDIAFOREUROPE NV B	3.792	+213.65%	29.05K
Frontline	251.20	+121.71%	13.39K
Guerbet	35.75	+117.72%	0.13K

Name	Last	Chg. %	Vol.
Express	0.69	-81.98%	0.10K
H Lundbeck B	32.60	-81.24%	35.02K
BioGaia B	113.70	-77.94%	1.52K
Hydrogen Refueling	4.83	-67.19%	0.01K
Palatin	1.68	-59.02%	0.07K
Tomra Systems	148.50	-57.30%	14.11K
Atlas Copco B	162.10	-57.10%	101.97K